Click here to view the United Healthcare (UHC) Medical Policy Updates » November 2024 United…
BCBS Louisiana Medical Policy Updates – June 2018
June 2018 Medical Policy Updates:
- Amniotic Membrane and Amniotic Fluid
- Angiotensin Converting Enzyme-Inhibitors and Angiotensin Converting Enzyme-Inhibitor Combination Drugs
- Artificial Intervertebral Disc: Cervical Spine
- Artificial Intervertebral Disc: Lumbar Spine
- Automatic Implantable Cardioverter Defibrillator (AICD)
- Balloon Dilation of the Eustachian Tube
- belimumab (Benlysta )
- bezlotoxumab (Zinplava )
- Bioengineered Skin and Soft Tissue Substitutes
- Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure
- certolizumab pegol (Cimzia )
- Chimeric Antigen Receptor T cell Therapy (CAR-T)
- Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
- Cochlear Implant
- Cryosurgical Ablation of Breast Fibroadenomas
- desmopressin acetate (Noctiva™)
- dichlorphenamide (Keveyis )
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, DPP-4 Inhibitor Combination Drugs, Cycloset (bromocriptine)
- External Insulin Pump
- Fetal Surgery for Prenatally Diagnosed Malformations
- Gene Expression Profiling for Uveal Melanoma
- Gene Expression-Based Assays for Cancers of Unknown Primary
- Genetic Testing for Epilepsy
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Genetic Testing for PTEN Hamartoma Tumor Syndrome
- Genetic Testing for Warfarin Dose
- Hematopoietic Cell Transplantation for Autoimmune Diseases
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for Hodgkin Lymphoma
- Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
- Hippotherapy
- hydroxyprogesterone caproate Injection (Makena )
- In Vitro Chemoresistance and Chemosensitivity Assays
- Keratoprosthesis
- L-Glutamine (Endari )
- Lyrica CR (pregabalin)
- Magnetic Resonance Spectroscopy
- Meniscal Allografts and Other Meniscal Implants
- Nerve Graft in Association With Radical Prostatectomy
- nusinersen (Spinraza™)
- ocrelizumab (Ocrevus™)
- Ophthalmic Prostaglandins
- Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used With Autologous Bone Marrow)
- Positron Emission Mammography (PEM)
- Positron Emission Mammography (PEM)
- Positron Emission Tomography (PET) Cardiac Applications
- Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors [alirocumab (Praluent ), evolocumab (Repatha )]
- Radiofrequency Ablation of Peripheral Nerves to Treat Pain
- sebelipase alfa (Kanuma )
- Surgical Ventricular Restoration
- Synthetic Cartilage Implants for Joint Pain
- telotristat (Xermelo™)
- tezacaftor/ivacaftor (Symdeko )
- Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies
- Treatment of Hepatitis C with Pegylated Interferon, Ribavirin and/or Telaprevir (Incivek ) and Boceprevir (Victrelis )
- Trimpex (trimethoprim oral solution)
- Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis
- uridine triacetate (Xuriden )
- vestronidase alfa-vjbk (Mepsevii™)
Click here to view the Blue Cross Blue Shield Louisiana Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.